Editorial: Novel Therapeutic Target and Drug Development in Neurovascular Retinal Diseases

Front Pharmacol. 2021 Apr 15:12:657684. doi: 10.3389/fphar.2021.657684. eCollection 2021.

Authors

Zhuo Shao¹, Zhongxiao Wang², Amy C Y Lo³, Zhongjie Fu²

Affiliations

¹ Division of Clinical and Metabolic Genetics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
² Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States.
³ Department of Ophthalmology, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, China.

No abstract available

Keywords: drug discovery; epigenetic modification; metabolism; microfluidics; neovascularization; retina; retinopathy; small peptide.

Publication types

Editorial